Chihiro Matsumoto
Kumamoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
ASO Visual Abstract: Early Tumor Shrinkage and Clinical Outcomes in Esophageal Squamous Cell Carcinoma Patients Treated with Immune Checkpoint Inhibitors: Real-World Observational Study.
Journal: Annals of surgical oncology
Published: June 08, 2026
Comprehensive Analysis of Spatial and Temporal Tumor Heterogeneity of Immune Checkpoint Molecules in GastricCancer
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: May 25, 2026
ASO Author Reflections: Early Tumor Shrinkage: An Early Signal of Benefit From Immune Checkpoint Inhibitors in ESCC.
Journal: Annals of surgical oncology
Published: May 18, 2026
ASO Visual Abstract: Prognosis After Curative Resection of Esophageal Basaloid Squamous Cell Carcinoma: A Single-Institution Retrospective Study.
Journal: Annals of surgical oncology
Published: May 10, 2026
Modified transferrin saturation is associated with postoperative complications in patients undergoing curative gastrectomy for gastric cancer.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: April 07, 2026
Genomic and transcriptomic landscape of carcinogenesis in patients with gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS).
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 31, 2025
Early Tumor Shrinkage and Clinical Outcomes for Esophageal Squamous Cell Carcinoma Patients Treated with Immune Checkpoint Inhibitors: Real-World Observational Study.
Journal: Annals of surgical oncology
Published: September 12, 2025
Minimally invasive colectomy May contribute to a better long-term prognosis for patients when a textbook outcome is not achieved.
Journal: Surgery today
Published: July 15, 2025
Prognosis After Curative Resection of Esophageal Basaloid Squamous Cell Carcinoma: A Single-Institution Retrospective Study.
Journal: Annals of surgical oncology
Published: April 14, 2025
Cytotoxic Anti-tumor Drugs and Tumor-Associated Macrophages Synergistically Surge PD-L1 Expression in Esophageal Squamous Cell Carcinoma.
Journal: Annals of surgical oncology
Published: April 03, 2025
Identification of the Inflammatory Cytokine Tumor Necrosis Factor Superfamily 4 as an Oncogenic Driver and Potential Druggable Target in Hepatocellular Carcinoma.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: January 10, 2025
Last Updated: 09/26/2026